UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Pinduoduo
PDD
|
$1.65B |
| 2 |
Accenture
ACN
|
$1.54B |
| 3 |
Linde
LIN
|
$1.24B |
| 4 |
Prologis
PLD
|
$1.08B |
| 5 |
Microsoft
MSFT
|
$914M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$809M |
| 2 |
Blackrock
BLK
|
$809M |
| 3 |
Lam Research
LRCX
|
$735M |
| 4 |
Meta Platforms (Facebook)
META
|
$563M |
| 5 |
UBS Group
UBS
|
$411M |
Sector Composition
| 1 | Technology | 33.21% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2651
CEMIG Preferred Shares
CIG
$5.86B
| $313K | ﹤0.01% |
+151,900
| New | +$313K |
|
2652
Invesco S&P International Developed Low Volatility ETF
IDLV
$330M
| $311K | ﹤0.01% |
+10,231
| New | +$311K |
|
2653
Ibotta
IBTA
$770M
| $308K | ﹤0.01% |
+5,007
| New | +$308K |
|
2654
Movado Group
MOV
$427M
| $307K | ﹤0.01% |
16,494
-21,258
| -56% | -$395K |
|
2655
OrthoPediatrics
KIDS
$521M
| $305K | ﹤0.01% |
11,232
-2,588
| -19% | -$70.2K |
|
2656
Olaplex Holdings
OLPX
$1.02B
| $302K | ﹤0.01% |
128,338
-50,799
| -28% | -$119K |
|
2657
Ginkgo Bioworks
DNA
$648M
| $295K | ﹤0.01% |
36,249
-11,291
| -24% | -$92K |
|
2658
Bank of N.T. Butterfield & Son
NTB
$1.87B
| $295K | ﹤0.01% |
8,000
| – | – |
|
|
OBE
2659
Obsidian Energy
OBE
$396M
| $283K | ﹤0.01% |
51,092
-73,519
| -59% | -$407K |
|
2660
Westrock Coffee
WEST
$517M
| $279K | ﹤0.01% |
42,879
-4,036
| -9% | -$26.2K |
|
|
SENEB
2661
Seneca Foods Class B
SENEB
| $278K | ﹤0.01% |
4,500
| – | – |
|
2662
Astera Labs
ALAB
$31.3B
| $277K | ﹤0.01% |
5,284
+284
| +6% | +$14.9K |
|
2663
Excelerate Energy
EE
$750M
| $276K | ﹤0.01% |
12,541
-4,954
| -28% | -$109K |
|
2664
Lyell Immunopharma
LYEL
$232M
| $270K | ﹤0.01% |
9,795
+165
| +2% | +$4.55K |
|
2665
Savers
SVV
$1.98B
| $252K | ﹤0.01% |
+23,939
| New | +$252K |
|
2666
Ternium
TX
$6.8B
| $251K | ﹤0.01% |
6,800
| – | – |
|
2667
NVE Corp
NVEC
$321M
| $240K | ﹤0.01% |
3,000
| – | – |
|
2668
Oric Pharmaceuticals
ORIC
$1.09B
| $236K | ﹤0.01% |
23,034
-19,286
| -46% | -$198K |
|
2669
Boston Omaha
BOC
$417M
| $235K | ﹤0.01% |
15,787
-3,803
| -19% | -$56.6K |
|
|
NYAX
2670
Nayax
NYAX
$1.84B
| $228K | ﹤0.01% |
9,040
-317
| -3% | -$7.99K |
|
2671
Entrada Therapeutics
TRDA
$209M
| $226K | ﹤0.01% |
14,156
+3,644
| +35% | +$58.2K |
|
|
ENFN
2672
DELISTED
Enfusion, Inc.
ENFN
| $223K | ﹤0.01% |
23,548
-57
| -0.2% | -$541 |
|
2673
Bitdeer Technologies
BTDR
$2.64B
| $220K | ﹤0.01% |
+28,072
| New | +$220K |
|
2674
Centuri Holdings
CTRI
$1.89B
| $211K | ﹤0.01% |
+13,086
| New | +$211K |
|
|
EVV
2675
Eaton Vance Limited Duration Income Fund
EVV
$1.2B
| $210K | ﹤0.01% |
20,000
-15,000
| -43% | -$158K |
|